Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Bays H, Schwartz S, Littlejohn T, Kerzner B, Krauss R, Wang X, Choi Y, Karpf D, Roberts B. Abstract: 515 MBX8025, A NOVEL PPARΔ AGONIST: LIPID & METABOLIC EFFECTS IN DYSLIPIDEMIC OVERWEIGHT PATIENTS. ATHEROSCLEROSIS SUPP 2009. [DOI: 10.1016/s1567-5688(09)70261-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]

For:	Bays H, Schwartz S, Littlejohn T, Kerzner B, Krauss R, Wang X, Choi Y, Karpf D, Roberts B. Abstract: 515 MBX8025, A NOVEL PPARΔ AGONIST: LIPID & METABOLIC EFFECTS IN DYSLIPIDEMIC OVERWEIGHT PATIENTS. ATHEROSCLEROSIS SUPP 2009. [DOI: 10.1016/s1567-5688(09)70261-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]

Number

Cited by Other Article(s)

Brown WV, Bays H, Davidson M, Goldberg A. Drugs in development for management of lipoprotein disorders. J Clin Lipidol 2011;5:66-75. [PMID: 21392719 DOI: 10.1016/j.jacl.2011.01.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2011] [Accepted: 01/19/2011] [Indexed: 10/18/2022]